GGrantIndex
← Search

ACTG 362: TRIAL TO DETERMINE EFFICACY OF AZITHROMYCIN FOR MYCOBAC AVI

$0M01FY2000RRNIH

University Of Rochester, Rochester NY

Investigators

Linked publications & trials

Abstract

Compare the time to development of MAC disease in subjects receiving Azithromycin to those receiving placebo amoung subjects who have had an increase in their CD4 count from below 50cells/mm3 to above 100 cells/mm3 and to evaluate the association between HIV rna levels at baseline and during follow-up and risk of MAC disease and other opportunistic infections.

View original record on NIH RePORTER →